Exosens Stock Hits a Record High of €73.5 at Opening
EXOSENS stock shows a significant increase this Wednesday, March 18, trading at €73.5 during the session, up 2.23% from the last close at €71.9. The stock simultaneously crosses two significant thresholds: a new all-time high surpassing the previous record of €72.8, and a monthly change exceeding 20%, two signals that cumulatively put the stock in the spotlight. These movements occur in a well-oriented Parisian market context, with the CAC 40 up 0.87% during the session.
This morning, EXOSENS sets a new absolute record at €73.5, thus surpassing the previous historical high of €72.8. This progression is part of a particularly marked monthly dynamic, with a gain exceeding 20% over the last thirty rolling days, a threshold that anomaly detection algorithms consider a statistical anomaly compared to the usual behavior of the stock. On broader horizons, the performance remains remarkable: the stock shows a gain of 8.41% over seven days, 23.95% over three months, and 115.8% over one year, reflecting a deep revaluation of the stock from last year's levels. However, the general context remains marked by measured tension, with the VIX at 27.19, a level indicating still high implied volatility in the equity markets.
Technical Analysis Perspective
Free · Every morning
Technical market signals, before the opening bell.
Bullish and bearish momentum, analyst changes, stocks to watch — automatically computed from Euronext data.
✓ Before 9 AM every morning✓ Euronext data✓ AI-powered analysis
Almost there! Check your inbox.
A confirmation email has been sent. Click the link to confirm your subscription.
An error occurred.
Indicative data. No investment advice. Unsubscribe at any time.
From a technical analysis standpoint, the stock is trading well above its two reference moving averages: the MM50 stands at €58.73 and the MM200 at €47.04, levels now respectively €15 and €26 away from the current price. This positioning reflects a well-established structural upward trend, maintained over several months. The RSI is at 75, indicating a technical overbought territory, which shows that the buying dynamics have been particularly strong in the recent period. Moreover, the stock crosses the upper Bollinger band, set at €72.20, confirming that the ongoing movement is outside the statistically usual amplitudes for the stock. The next milestone to watch on the company's financial calendar is the publication of the first quarter 2026 results, expected on April 27.
Nous sommes fiers de présenter notre performance sur les neuf premiers mois de l’année 2025, qui témoignent d'une croissance soutenue du chiffre d'affaires et de la marge brute ajustée, portée par la forte dynamique du secteur de la Défense.
Marché de la Défense très dynamique, forte demande pour la vision nocturne et les systèmes pour drones/anti-drones, croissance soutenue en Europe avec contribution des États-Unis et de l’Asie-Pacifique. Lancement commercial réussi des tubes 5G (plus de 5 000 commandes avant lancement).
Risks mentioned
Cession de l’activité Amplification par Micro-ondes entraînant une perte comptable sans impact de trésorerie en 2025
Dépendance aux budgets de Défense et aux évolutions géopolitiques
Risque d'intégration des acquisitions récentes
Incertitudes de la demande dans les Sciences de la Vie (marché américain)
Opportunities identified
Croissance adressable liée à la vision nocturne et aux applications drones/anti-drones
Commercialisation des tubes 5G avec commandes significatives (>5 000 tubes)
Expansion des capacités de production (+40% d’ici 2027) soutenant le développement commercial
Effets de croissance externe (Noxant, NVLS, Phasics) élargissant le marché adressable
The information presented in this article is provided for informational purposes only and does not constitute an investment recommendation, an incentive to buy or sell a financial asset, or investment advice. Readers are invited to conduct their own research before making any decision.
Investments in the stock market involve risks, including the risk of capital loss. Past performance of an asset or market is no guarantee of future results. Any investment decision should be made taking into account your personal financial situation, objectives and risk tolerance.
